NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly) AND Familial hypercholesterolemia

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Nov 13, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003581626.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly)]

NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly)

Gene:

LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

19p13.2

Genomic location:

Preferred name:

NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly)

Other names:

NM_000527.5(LDLR):c.1445A>G; p.Asp482Gly

HGVS:

NC_000019.10:g.11113621A>G
NG_009060.1:g.29241A>G
NM_000527.5:c.1445A>GMANE SELECT
NM_001195798.2:c.1445A>G
NM_001195799.2:c.1322A>G
NM_001195800.2:c.941A>G
NM_001195803.2:c.1064A>G
NP_000518.1:p.Asp482Gly
NP_001182727.1:p.Asp482Gly
NP_001182728.1:p.Asp441Gly
NP_001182729.1:p.Asp314Gly
NP_001182732.1:p.Asp355Gly
LRG_274:g.29241A>G
NC_000019.9:g.11224297A>G
c.1445A>G

Protein change:

D314G

Links:

LDLR-LOVD, British Heart Foundation: LDLR_000200; dbSNP: rs879254904

NCBI 1000 Genomes Browser:

rs879254904

Molecular consequence:

NM_000527.5:c.1445A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001195798.2:c.1445A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001195799.2:c.1322A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001195800.2:c.941A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001195803.2:c.1064A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Familial hypercholesterolemia
Identifiers:: MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Clear Turn Off Turn On

Mus musculus collagen, type XI, alpha 1 (Col11a1), mRNA
Mus musculus collagen, type XI, alpha 1 (Col11a1), mRNA
gi|959092928|ref|NM_007729.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004298360	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely pathogenic (Nov 13, 2023)	germline	clinical testing	PubMed (7) [See all records that cite these PMIDs] 20145306, 8535447, 16389549, 20236128, 21310417, 23375686, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004298360

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely pathogenic
(Nov 13, 2023)

germline

clinical testing

PubMed (7)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.

Chmara M, Wasag B, Zuk M, Kubalska J, Wegrzyn A, Bednarska-Makaruk M, Pronicka E, Wehr H, Defesche JC, Rynkiewicz A, Limon J.

J Appl Genet. 2010;51(1):95-106. doi: 10.1007/BF03195716.

PubMed [citation]

PMID:: 20145306

Three novel mutations in the EGF precursor homology domain of the low-density lipoprotein receptor gene in Northern Irish patients with familial hypercholesterolemia.

Ward AJ, O'Kane M, Young I, Nicholls DP, Nevin NC, Graham CA.

Hum Mutat. 1995;6(3):254-6. No abstract available.

PubMed [citation]

PMID:: 8535447

See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004298360.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (7)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 482 of the LDLR protein (p.Asp482Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with familial hypercholesterolemia (PMID: 20145306; Invitae). ClinVar contains an entry for this variant (Variation ID: 251846). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function with a positive predictive value of 95%. This variant disrupts the p.Asp482 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8535447, 16389549, 20236128, 21310417, 23375686). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine